

<!DOCTYPE html>
<html lang="zh-CN" >



<head>
  <meta charset="UTF-8">

  <link rel="apple-touch-icon" sizes="76x76" href="/img/Logo.png">
  <link rel="icon" href="/img/Logo.png">
  

  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0, shrink-to-fit=no">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  
  <meta name="theme-color" content="#2f4154">
  <meta name="author" content="向海">
  <meta name="keywords" content="">
  
    <meta name="description" content="Drugs for diabetes">
<meta property="og:type" content="article">
<meta property="og:title" content="L16 Antidiabetic Drugs">
<meta property="og:url" content="https://zhenyumi.github.io/posts/56abcc83/index.html">
<meta property="og:site_name" content="鹘横海">
<meta property="og:description" content="Drugs for diabetes">
<meta property="og:locale" content="zh_CN">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530173844721.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174516867.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174602159.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174623837.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174634215.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174645290.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174711879.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174723600.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174941064.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175020253.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175114056.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175523192.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175951384.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530180716678.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530180814027.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530181121585.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530181130864.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530181548941.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530182500563.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530182910480.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530182959370.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183156104.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183513757.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183522862.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183526465.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183532050.png">
<meta property="article:published_time" content="2021-06-01T07:47:16.000Z">
<meta property="article:modified_time" content="2021-06-01T07:47:16.000Z">
<meta property="article:author" content="向海">
<meta property="article:tag" content="Molecular Pharmacology">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530173844721.png">
  
  
  
  <title>L16 Antidiabetic Drugs - 鹘横海</title>

  <link  rel="stylesheet" href="https://lib.baomitu.com/twitter-bootstrap/4.6.1/css/bootstrap.min.css" />



  <link  rel="stylesheet" href="https://lib.baomitu.com/github-markdown-css/4.0.0/github-markdown.min.css" />

  <link  rel="stylesheet" href="https://lib.baomitu.com/hint.css/2.7.0/hint.min.css" />

  <link  rel="stylesheet" href="https://lib.baomitu.com/fancybox/3.5.7/jquery.fancybox.min.css" />



<!-- 主题依赖的图标库，不要自行修改 -->
<!-- Do not modify the link that theme dependent icons -->

<link rel="stylesheet" href="//at.alicdn.com/t/c/font_1749284_5i9bdhy70f8.css">



<link rel="stylesheet" href="//at.alicdn.com/t/c/font_1736178_k526ubmyhba.css">


<link  rel="stylesheet" href="/css/main.css" />


  <link id="highlight-css" rel="stylesheet" href="/css/highlight.css" />
  




  <script id="fluid-configs">
    var Fluid = window.Fluid || {};
    Fluid.ctx = Object.assign({}, Fluid.ctx)
    var CONFIG = {"hostname":"zhenyumi.github.io","root":"/","version":"1.9.8","typing":{"enable":true,"typeSpeed":70,"cursorChar":"_","loop":false,"scope":["home"]},"anchorjs":{"enable":true,"element":"h1,h2,h3,h4,h5,h6","placement":"left","visible":"hover","icon":""},"progressbar":{"enable":true,"height_px":3,"color":"#29d","options":{"showSpinner":false,"trickleSpeed":100}},"code_language":{"enable":true,"default":"TEXT"},"copy_btn":true,"image_caption":{"enable":true},"image_zoom":{"enable":true,"img_url_replace":["",""]},"toc":{"enable":true,"placement":"right","headingSelector":"h1,h2,h3,h4,h5,h6","collapseDepth":0},"lazyload":{"enable":true,"loading_img":"/img/loading.gif","onlypost":false,"offset_factor":2},"web_analytics":{"enable":false,"follow_dnt":true,"baidu":null,"google":{"measurement_id":null},"tencent":{"sid":null,"cid":null},"leancloud":{"app_id":null,"app_key":null,"server_url":null,"path":"window.location.pathname","ignore_local":false},"umami":{"src":null,"website_id":null,"domains":null,"start_time":"2024-01-01T00:00:00.000Z","token":null,"api_server":null}},"search_path":"/local-search.xml","include_content_in_search":true};

    if (CONFIG.web_analytics.follow_dnt) {
      var dntVal = navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack;
      Fluid.ctx.dnt = dntVal && (dntVal.startsWith('1') || dntVal.startsWith('yes') || dntVal.startsWith('on'));
    }
  </script>
  <script  src="/js/utils.js" ></script>
  <script  src="/js/color-schema.js" ></script>
  


  
<meta name="generator" content="Hexo 7.0.0"></head>


<body>
  

  <header>
    

<div class="header-inner" style="height: 70vh;">
  <nav id="navbar" class="navbar fixed-top  navbar-expand-lg navbar-dark scrolling-navbar">
  <div class="container">
    <a class="navbar-brand" href="/">
      <strong>鹘横海</strong>
    </a>

    <button id="navbar-toggler-btn" class="navbar-toggler" type="button" data-toggle="collapse"
            data-target="#navbarSupportedContent"
            aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
      <div class="animated-icon"><span></span><span></span><span></span></div>
    </button>

    <!-- Collapsible content -->
    <div class="collapse navbar-collapse" id="navbarSupportedContent">
      <ul class="navbar-nav ml-auto text-center">
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/" target="_self">
                <i class="iconfont icon-home-fill"></i>
                <span>首页</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/archives/" target="_self">
                <i class="iconfont icon-archive-fill"></i>
                <span>归档</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/categories/" target="_self">
                <i class="iconfont icon-category-fill"></i>
                <span>分类</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/tags/" target="_self">
                <i class="iconfont icon-tags-fill"></i>
                <span>标签</span>
              </a>
            </li>
          
        
          
          
          
          
            <li class="nav-item">
              <a class="nav-link" href="/about/" target="_self">
                <i class="iconfont icon-user-fill"></i>
                <span>关于</span>
              </a>
            </li>
          
        
        
          <li class="nav-item" id="search-btn">
            <a class="nav-link" target="_self" href="javascript:;" data-toggle="modal" data-target="#modalSearch" aria-label="Search">
              <i class="iconfont icon-search"></i>
            </a>
          </li>
          
        
        
      </ul>
    </div>
  </div>
</nav>

  

<div id="banner" class="banner" parallax=true
     style="background: url('https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/Fluid/post/post2.jpg') no-repeat center center; background-size: cover;">
  <div class="full-bg-img">
    <div class="mask flex-center" style="background-color: rgba(0, 0, 0, 0.3)">
      <div class="banner-text text-center fade-in-up">
        <div class="h2">
          
            <span id="subtitle">L16 Antidiabetic Drugs</span>
          
        </div>

        
          
  <div class="mt-3">
    
    
      <span class="post-meta">
        <i class="iconfont icon-date-fill" aria-hidden="true"></i>
        <time datetime="2021-06-01 15:47" pubdate>
          2021年6月1日 下午
        </time>
      </span>
    
  </div>

  <div class="mt-1">
    
      <span class="post-meta mr-2">
        <i class="iconfont icon-chart"></i>
        
          245 字
        
      </span>
    

    
      <span class="post-meta mr-2">
        <i class="iconfont icon-clock-fill"></i>
        
        
        
          3 分钟
        
      </span>
    

    
    
  </div>


        
      </div>

      
    </div>
  </div>
</div>

</div>

  </header>

  <main>
    
      

<div class="container-fluid nopadding-x">
  <div class="row nomargin-x">
    <div class="side-col d-none d-lg-block col-lg-2">
      

    </div>

    <div class="col-lg-8 nopadding-x-md">
      <div class="container nopadding-x-md" id="board-ctn">
        <div id="board">
          <article class="post-content mx-auto">
            <h1 id="seo-header">L16 Antidiabetic Drugs</h1>
            
            
              <div class="markdown-body">
                
                <h1 id="一、The-Pancreas"><a href="#一、The-Pancreas" class="headerlink" title="一、The Pancreas"></a>一、The Pancreas</h1><p>An organ that makes insulin and enzymes for digestion (excorine function).</p>
<p>Both <strong>endocrine system</strong> and <strong>digestive system</strong> (exocrine)</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530173844721.png" srcset="/img/loading.gif" lazyload alt="image-20210530173844721"></p>
<h2 id="Pancreatic-islet-cells-and-their-secretory-products"><a href="#Pancreatic-islet-cells-and-their-secretory-products" class="headerlink" title="Pancreatic islet cells and their secretory products"></a>Pancreatic islet cells and their secretory products</h2><p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174516867.png" srcset="/img/loading.gif" lazyload alt="image-20210530174516867"></p>
<ul>
<li><strong>Insulin</strong>: the storage and anabolic hormone of the body (glycometabolism)</li>
<li><strong>Amylin</strong>: modulates appetite, gastric emptying, and glucagon and insulin secretion</li>
<li><strong>Glucagon</strong>: the hyperglycemic factor that mobilizes glycogen stores</li>
</ul>
<h2 id="Disorders-of-the-Pancreas-Diabetes-Mellitus"><a href="#Disorders-of-the-Pancreas-Diabetes-Mellitus" class="headerlink" title="Disorders of the Pancreas: Diabetes Mellitus"></a>Disorders of the Pancreas: Diabetes Mellitus</h2><p>Caused by:</p>
<ul>
<li>Insufficient secretion of insulin</li>
<li>Resistance of body cells to the effects of insulin</li>
</ul>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174602159.png" srcset="/img/loading.gif" lazyload alt="image-20210530174602159"></p>
<p>One model of control of insulin release from the pancreatic B cell</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174623837.png" srcset="/img/loading.gif" lazyload alt="image-20210530174623837"></p>
<p>Insulin-induces glucose uptake in muscle, fat, liver, and brain</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174634215.png" srcset="/img/loading.gif" lazyload alt="image-20210530174634215"></p>
<p>Insulin induces glucose transporter (Glut) surface relocation</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174645290.png" srcset="/img/loading.gif" lazyload alt="image-20210530174645290"></p>
<h2 id="Glucose-transporters-GLUT"><a href="#Glucose-transporters-GLUT" class="headerlink" title="Glucose transporters (GLUT)"></a>Glucose transporters (GLUT)</h2><p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174711879.png" srcset="/img/loading.gif" lazyload alt="image-20210530174711879"></p>
<h2 id="Insulin-promotes-glycogen-synthesis-and-storage"><a href="#Insulin-promotes-glycogen-synthesis-and-storage" class="headerlink" title="Insulin promotes glycogen synthesis and storage"></a>Insulin promotes glycogen synthesis and storage</h2><p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174723600.png" srcset="/img/loading.gif" lazyload alt="image-20210530174723600"></p>
<h3 id="1-Endocrine-effects-of-insulin"><a href="#1-Endocrine-effects-of-insulin" class="headerlink" title="1. Endocrine effects of insulin"></a>1. Endocrine effects of insulin</h3><p><strong>Effect on liver:</strong> </p>
<ul>
<li>Inhibits glycogenolysis</li>
<li>Inhibits conversion of fatty acids and amino acids to Acetyl-CoA</li>
</ul>
<p><strong>Anabolic action</strong></p>
<ul>
<li>Promotes glucose storage as glycogen (induces glucokinase and glycogen synthase, inhibits phosphorylase)</li>
<li>Increases triglyceride synthesis and very-low-density lipoprotein formation</li>
</ul>
<p><strong>Effect on muscle:</strong> </p>
<ul>
<li>Increased protein synthesis </li>
<li>Increases amino acid transport </li>
<li>Increases ribosomal protein synthesis </li>
<li>Increased glycogen synthesis </li>
<li>Increases glucose transport</li>
<li>Induces glycogen synthase and inhibits phosphorylase</li>
</ul>
<p><strong>Effect on adipose tissue:</strong> </p>
<ul>
<li>Increased triglyceride storage</li>
<li>Glucose transport into cell provides glycerol phosphate to permit esterification of fatty acids supplied by lipoprotein transport</li>
<li>Intracellular lipase is inhibited by insulin</li>
</ul>
<h1 id="二、Diabetes-Mellitus"><a href="#二、Diabetes-Mellitus" class="headerlink" title="二、Diabetes Mellitus"></a>二、Diabetes Mellitus</h1><h2 id="Types"><a href="#Types" class="headerlink" title="Types"></a>Types</h2><p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530174941064.png" srcset="/img/loading.gif" lazyload alt="image-20210530174941064"></p>
<h3 id="1-TypeⅠ-Diabetes"><a href="#1-TypeⅠ-Diabetes" class="headerlink" title="1. TypeⅠ Diabetes"></a>1. TypeⅠ Diabetes</h3><p>develops suddenly, usually before age 15</p>
<ul>
<li>results in insulin dependence </li>
<li>severe or absolute insulin deficiency</li>
</ul>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175020253.png" srcset="/img/loading.gif" lazyload alt="image-20210530175020253"></p>
<ul>
<li>Type I diabetes occurs when <strong>insulin producing cells</strong> are destroyed by the body’s <strong>own immune system</strong></li>
</ul>
<h3 id="2-Treatment-of-Type-Ⅰ-Diabetes"><a href="#2-Treatment-of-Type-Ⅰ-Diabetes" class="headerlink" title="2. Treatment of Type Ⅰ Diabetes"></a>2. Treatment of Type Ⅰ Diabetes</h3><p>Injection of insulin</p>
<p>Surgery: replacing the pancreas or just the beta cells</p>
<ul>
<li>pancreas-kidney transplant</li>
<li>Stem cell research</li>
</ul>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175114056.png" srcset="/img/loading.gif" lazyload alt="image-20210530175114056" style="zoom:67%;" />

<h3 id="3-Type-Ⅲ-Diabetes-–-GDM"><a href="#3-Type-Ⅲ-Diabetes-–-GDM" class="headerlink" title="3. Type Ⅲ Diabetes – GDM"></a>3. Type Ⅲ Diabetes – GDM</h3><p><strong>Gestational diabetes mellitus (GDM, 妊娠期糖尿病)</strong> is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy</p>
<p>Most patients are treated only with diet modification and moderate exercise but some take anti-diabetic drugs, including insulin therapy.</p>
<h3 id="4-Type-Ⅳ-Diabetes"><a href="#4-Type-Ⅳ-Diabetes" class="headerlink" title="4. Type Ⅳ Diabetes"></a>4. Type Ⅳ Diabetes</h3><p>Other specific types</p>
<p>Drug-induced diabetes : </p>
<ul>
<li>1992, anti-hypertensive vasodilator diazoxide, and corticosteroids in high doses could cause diabetes.</li>
<li>2006, antipsychotic drugs： Olanzapine: induces hyperinsulinemia. dozens of those patients died from diabetes-related complications.</li>
</ul>
<h3 id="5-Type-Ⅱ-Diabetes"><a href="#5-Type-Ⅱ-Diabetes" class="headerlink" title="5. Type Ⅱ Diabetes"></a>5. Type Ⅱ Diabetes</h3><p>adult onset, usually occurs after age 40</p>
<p><strong>Etiology</strong>: Insulin resistance; relative deficiency in insulin secretion (late stage).</p>
<p>blood glucose levels rise due to :</p>
<ul>
<li>Lack of insulin production</li>
<li>Insufficient insulin action (resistant cells)</li>
</ul>
<h3 id="6-Treatment-of-TypeⅡ-Diabetes"><a href="#6-Treatment-of-TypeⅡ-Diabetes" class="headerlink" title="6. Treatment of TypeⅡ Diabetes"></a>6. Treatment of TypeⅡ Diabetes</h3><h4 id="Drugs"><a href="#Drugs" class="headerlink" title="Drugs"></a>Drugs</h4><p>Oral hypoglycemic agent &#x3D; OHA</p>
<p>OHA s + Insulin therapy</p>
<h4 id="Surgery"><a href="#Surgery" class="headerlink" title="Surgery"></a>Surgery</h4><p>Surgery: Type 2 diabetes can be cured gastric bypass surgery in 80-100% of Severely obese patients</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175523192.png" srcset="/img/loading.gif" lazyload alt="image-20210530175523192"></p>
<h2 id="Treatment"><a href="#Treatment" class="headerlink" title="Treatment"></a>Treatment</h2><p><strong>Antidiabetic Drugs</strong></p>
<ul>
<li><font color="FF0000">Insulin</font></li>
<li>Insulin <strong>Secretagogues</strong>: Sulfonylureas; Meglitinides</li>
<li>Insulin <strong>Sensitisers</strong>: Biguanides; Thiazolidinediones</li>
<li>Alpha-glucosidase inhibitors</li>
<li>Peptide analogs:<ul>
<li>Glucagon-like peptide (GLP) analogs</li>
<li>DPP-4 inhibitors</li>
<li>Amylin analogues</li>
</ul>
</li>
</ul>
<h3 id="1-Insulin"><a href="#1-Insulin" class="headerlink" title="1. Insulin"></a>1. Insulin</h3><h4 id="Application"><a href="#Application" class="headerlink" title="Application"></a>Application</h4><p>Diabetes mellitus <strong>type 1</strong> is a disease caused by the lack of insulin</p>
<p>Insulin <font color="0000FF">must</font> be used in Type I, which must be injected or inhaled.</p>
<p><strong>Pharmacological effects of insulin</strong></p>
<ul>
<li>Decrease the blood glucose concentration (BGC)</li>
</ul>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530175951384.png" srcset="/img/loading.gif" lazyload alt="image-20210530175951384"></p>
<p>Insulin preparation</p>
<ul>
<li>Rapid-acting, Short-acting, Intermediate-acting, Long-acting</li>
</ul>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530180716678.png" srcset="/img/loading.gif" lazyload alt="image-20210530180716678"></p>
<h4 id="Delivery"><a href="#Delivery" class="headerlink" title="Delivery"></a>Delivery</h4><p><strong>Insulin Delivery System</strong></p>
<ul>
<li>Regular injections (Subcutaneous)</li>
<li>Portable pen injections</li>
<li>Continuous subcutaneous insulin infusion devices (CSII, insulin pumps)</li>
<li>Inhaled insulin</li>
</ul>
<p>Portable pen injections</p>
<ul>
<li>It is an insulin injection tool that resembles a pen. </li>
<li>This is great for people who need to give themselves an insulin injection when out in public but do not like it to be noticeable. </li>
<li>The Insulin Pen also contains memory of your last 16 injections</li>
</ul>
<p>Continuous Subcutaneous Insulin Infusion CSII</p>
<ul>
<li>Continuous infusion of a short-acting insulin driven by mechanical force and delivered via a needle or soft cannula under the skin.</li>
<li><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530180814027.png" srcset="/img/loading.gif" lazyload alt="image-20210530180814027"></li>
</ul>
<p>Inhaled insulin</p>
<ul>
<li>Inhaled insulin is a powdered form of insulin absorbed by the lungs through use of a hand-held inhaler. </li>
<li>Inhaled insulin is the first noninjectable option.</li>
</ul>
<h4 id="Complications-of-Insulin-Therapy"><a href="#Complications-of-Insulin-Therapy" class="headerlink" title="Complications of Insulin Therapy"></a>Complications of Insulin Therapy</h4><p>Hypoglycemia </p>
<p>Immunopathology: Insulin allergy; Immune insulin resistance (potential vicious cycle) </p>
<p>Lipodystrophy (abnormal accumulation of fat tissue) at injection sites</p>
<p><strong>Treatment of Hypoglycemia</strong></p>
<ul>
<li><strong>Glucagon</strong><ul>
<li>A hormone produced by the alpha cells in the pancreas. </li>
<li>It raises blood glucose. </li>
<li>An injectable form of glucagon</li>
</ul>
</li>
</ul>
<h3 id="2-Oral-hypoglycemic-agents"><a href="#2-Oral-hypoglycemic-agents" class="headerlink" title="2. Oral hypoglycemic agents"></a>2. Oral hypoglycemic agents</h3><h4 id="Insulin-Secretagogues"><a href="#Insulin-Secretagogues" class="headerlink" title="Insulin Secretagogues"></a>Insulin Secretagogues</h4><p>Insulin Secretagogues: agents which increase the amount of insulin secreted</p>
<h5 id="1-Sulfonylureas-SU"><a href="#1-Sulfonylureas-SU" class="headerlink" title="(1) Sulfonylureas (SU)"></a>(1) Sulfonylureas (SU)</h5><p>Sulfonylureas were the first widely used oral hypoglycemic medications</p>
<h6 id="Mechanism-of-Action"><a href="#Mechanism-of-Action" class="headerlink" title="Mechanism of Action"></a>Mechanism of Action</h6><p>trigger insulin release by direct action on the K channel of the pancreatic beta cells.</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530181121585.png" srcset="/img/loading.gif" lazyload alt="image-20210530181121585"></p>
<img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530181130864.png" srcset="/img/loading.gif" lazyload alt="image-20210530181130864" style="zoom:67%;" />

<h6 id="Therapeutic-uses"><a href="#Therapeutic-uses" class="headerlink" title="Therapeutic uses"></a>Therapeutic uses</h6><p>Only useful in Type II diabetes</p>
<ul>
<li>They work best with patients over 40 years old, who have had diabetes mellitus for under ten years</li>
</ul>
<p>Diabetes insipidus (large amount of urine)</p>
<ul>
<li><strong>Chlorpropamide</strong> has also an antidiuretic effect and may be used to treat diabetes insipidus.</li>
</ul>
<h6 id="Adverse-reactions"><a href="#Adverse-reactions" class="headerlink" title="Adverse reactions"></a>Adverse reactions</h6><p>Serious adverse reaction is <strong>hypoglycemia</strong></p>
<p>Common adverse effects: gastrointestinal reactions such as nausea and vomiting</p>
<h5 id="2-Meglitinides"><a href="#2-Meglitinides" class="headerlink" title="(2) Meglitinides"></a>(2) Meglitinides</h5><h6 id="Uses"><a href="#Uses" class="headerlink" title="Uses"></a>Uses</h6><p>Meglitinides help the pancreas produce insulin and are often called “short-acting secretagogues.”</p>
<p>Their mode of action is original, affecting <strong>potassium channels</strong></p>
<p>By closing the potassium channels of the pancreatic beta cells, they open the calcium channels, hence enhancing insulin secretion.</p>
<p>They are taken with meals to boost the insulin response to each meal.</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530181548941.png" srcset="/img/loading.gif" lazyload alt="image-20210530181548941"></p>
<p><strong>repaglinide</strong> (Prandin) The maximum dosage is 16 mg&#x2F;day, taken 0 to 30 minutes before meals. If a meal is skipped, the medication is also skipped.</p>
<p><strong>nateglinide</strong> (Starlix) The maximum dosage is 360 mg&#x2F;day, usually 120 mg three times a day (TID).</p>
<h6 id="Adverse-reactions-1"><a href="#Adverse-reactions-1" class="headerlink" title="Adverse reactions"></a>Adverse reactions</h6><p>weight gain</p>
<p>hypoglycemia</p>
<h4 id="Insulin-Sensitisers"><a href="#Insulin-Sensitisers" class="headerlink" title="Insulin Sensitisers"></a>Insulin Sensitisers</h4><p>Insulin Sensitisers: agents which increase the sensitivity of target to insulin</p>
<h5 id="1-Biguanides"><a href="#1-Biguanides" class="headerlink" title="(1) Biguanides"></a>(1) Biguanides</h5><h6 id="Mechanism-of-action"><a href="#Mechanism-of-action" class="headerlink" title="Mechanism of action"></a>Mechanism of action</h6><ul>
<li>Direct stimulation of glycolysis in tissues, with <u>increased glucose removal from blood</u></li>
<li>inhibiting gluconeogenesis</li>
<li>reducing the absorption of glucose from the intestine (influence on gut microbiota)</li>
</ul>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530182500563.png" srcset="/img/loading.gif" lazyload alt="image-20210530182500563"></p>
<h6 id="Therapeutic-uses-1"><a href="#Therapeutic-uses-1" class="headerlink" title="Therapeutic uses"></a>Therapeutic uses</h6><p>Metformin is usually the first-line medication used for treatment of type-2 diabetes.</p>
<h6 id="Adverse-reactions-2"><a href="#Adverse-reactions-2" class="headerlink" title="Adverse reactions"></a>Adverse reactions</h6><ul>
<li>The main adverse reactions of <strong>Phenformin are lactic acidosis (due to high glycolysis)</strong></li>
<li>The most frequent toxic effects of <strong>Metformin</strong> are gastrointestinal symptoms including nausea, vomiting, and diarrhea.</li>
</ul>
<h5 id="2-Thiazolidinediones-TZDs"><a href="#2-Thiazolidinediones-TZDs" class="headerlink" title="(2) Thiazolidinediones (TZDs)"></a>(2) Thiazolidinediones (TZDs)</h5><h6 id="Drugs-1"><a href="#Drugs-1" class="headerlink" title="Drugs"></a>Drugs</h6><ul>
<li>Pioglitazone</li>
<li>Rosiglitazone </li>
<li>Ciglitazone </li>
<li>Englitazone </li>
<li>Troglitazone</li>
</ul>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530182910480.png" srcset="/img/loading.gif" lazyload alt="image-20210530182910480"></p>
<h6 id="Mechanism-of-action-1"><a href="#Mechanism-of-action-1" class="headerlink" title="Mechanism of action"></a>Mechanism of action</h6><p>Enhance the target tissue’s sensitivity to insulin through <strong>PPARγ pathway</strong></p>
<p>PPAR-γ is a type of nuclear regulatory proteins involved in transcription of genes regulating glucose and fat metabolism. These PPARs act on Peroxysome Proliferator Responsive Elements (PPRE). The PPREs influence insulin sensitive genes, which enhance production of mRNAs of insulin dependent enzymes. The final result is <u>better use of glucose</u> by the cells.</p>
<h4 id="α-Glucosidase-Inhibitors"><a href="#α-Glucosidase-Inhibitors" class="headerlink" title="α-Glucosidase Inhibitors"></a>α-Glucosidase Inhibitors</h4><p>Alpha-glucosidase inhibitors: agents which decrease the rate at which glucose is absorbed from the gastrointestinal tract.</p>
<h5 id="1-Acarbose"><a href="#1-Acarbose" class="headerlink" title="(1) Acarbose"></a>(1) Acarbose</h5><p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530182959370.png" srcset="/img/loading.gif" lazyload alt="image-20210530182959370"></p>
<h6 id="Mechanism-of-action-2"><a href="#Mechanism-of-action-2" class="headerlink" title="Mechanism of action"></a>Mechanism of action</h6><p><strong>Reduces intestinal absorption</strong> of starch and dextrin by inhibiting the action of <strong>α-glucosidase</strong> in intestinal brush border.</p>
<h6 id="Clinical-use"><a href="#Clinical-use" class="headerlink" title="Clinical use"></a>Clinical use</h6><p>The agents are effective by themselves only in the earliest stages of <u>impaired glucose tolerance</u>, but can be helpful in combination with other agents in <u>type 2 diabetes</u></p>
<p>They do have the potential to cause weight loss by lowering the amount of sugar metabolized</p>
<h4 id="Peptide-analogs"><a href="#Peptide-analogs" class="headerlink" title="Peptide analogs"></a>Peptide analogs</h4><h5 id="Overview-of-insulin-secretion"><a href="#Overview-of-insulin-secretion" class="headerlink" title="Overview of insulin secretion"></a>Overview of insulin secretion</h5><p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183156104.png" srcset="/img/loading.gif" lazyload alt="image-20210530183156104"></p>
<p><strong>Incretin mimetics</strong></p>
<ul>
<li><strong>Incretins like GLP1</strong> are insulin secretagogues</li>
<li>The main candidate molecules that fulfill criteria for being an incretin are <strong>Glucagon-like peptide-1 (GLP-1)</strong></li>
<li>GLP-1 is rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4).</li>
</ul>
<h5 id="1-Glucagon-like-peptide-GLP-analogs"><a href="#1-Glucagon-like-peptide-GLP-analogs" class="headerlink" title="(1) Glucagon-like peptide (GLP) analogs"></a>(1) Glucagon-like peptide (GLP) analogs</h5><ul>
<li>GLP agonists bind to a membrane GLP receptor. </li>
<li>As a consequence of this, insulin release from the pancreatic beta cells is increased.</li>
</ul>
<p><strong>Exenatide</strong> (also Exendin-4, marketed as Byetta) is the first GLP agonist approved for the treatment of type 2 diabetes</p>
<p>It is an injectable medication. (<strong>liraglutide</strong>)</p>
<p>These agents may also cause a decrease in gastric motility, responsible for the common side effect of nausea, and is probably the mechanism by which weight loss occurs</p>
<h5 id="2-DPP-4-inhibitors"><a href="#2-DPP-4-inhibitors" class="headerlink" title="(2) DPP-4 inhibitors"></a>(2) DPP-4 inhibitors</h5><p><strong>Sitagliptin</strong></p>
<ul>
<li>an inhibitor of dipeptidyl peptidase-4 (DPP4), the enzyme that degrades incretin and other GLP-l-like molecules.</li>
<li>increase blood concentration of the incretin GLP-1 </li>
<li>This drug appears likely to be approved for use in type 2 diabetes.</li>
</ul>
<h5 id="3-Amylin-analogues"><a href="#3-Amylin-analogues" class="headerlink" title="(3) Amylin analogues"></a>(3) Amylin analogues</h5><p>Amylin agonist analogues <strong>slow gastric emptying</strong> and <strong>suppress glucagon</strong>.</p>
<p><strong>pramlintide</strong> is a clinically available amylin analogue. </p>
<p>Like insulin, it is administered by <strong>subcutaneous injection.</strong> </p>
<p>The most frequent and severe adverse effect of pramlintide is <strong>nausea</strong>, which occurs mostly at the beginning of treatment and gradually reduces.</p>
<hr>
<p><strong>Emerging concept:</strong> mild suppression of hyperinsulinemia in treatment obesity and insulin resistance</p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183513757.png" srcset="/img/loading.gif" lazyload alt="image-20210530183513757"></p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183522862.png" srcset="/img/loading.gif" lazyload alt="image-20210530183522862"></p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183526465.png" srcset="/img/loading.gif" lazyload alt="image-20210530183526465"></p>
<p><img src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210530183532050.png" srcset="/img/loading.gif" lazyload alt="image-20210530183532050"></p>

                
              </div>
            
            <hr/>
            <div>
              <div class="post-metas my-3">
  
    <div class="post-meta mr-3 d-flex align-items-center">
      <i class="iconfont icon-category"></i>
      

<span class="category-chains">
  
  
    
      <span class="category-chain">
        
  <a href="/categories/Academic-Notebook/" class="category-chain-item">Academic Notebook</a>
  
  
    <span>></span>
    
  <a href="/categories/Academic-Notebook/Molecular-Pharmacology/" class="category-chain-item">Molecular Pharmacology</a>
  
  

  

      </span>
    
  
</span>

    </div>
  
  
    <div class="post-meta">
      <i class="iconfont icon-tags"></i>
      
        <a href="/tags/Molecular-Pharmacology/" class="print-no-link">#Molecular Pharmacology</a>
      
    </div>
  
</div>


              
  

  <div class="license-box my-3">
    <div class="license-title">
      <div>L16 Antidiabetic Drugs</div>
      <div>https://zhenyumi.github.io/posts/56abcc83/</div>
    </div>
    <div class="license-meta">
      
        <div class="license-meta-item">
          <div>作者</div>
          <div>向海</div>
        </div>
      
      
        <div class="license-meta-item license-meta-date">
          <div>发布于</div>
          <div>2021年6月1日</div>
        </div>
      
      
      
        <div class="license-meta-item">
          <div>许可协议</div>
          <div>
            
              
              
                <a class="print-no-link" target="_blank" href="https://creativecommons.org/licenses/by/4.0/">
                  <span class="hint--top hint--rounded" aria-label="BY - 署名">
                    <i class="iconfont icon-cc-by"></i>
                  </span>
                </a>
              
            
          </div>
        </div>
      
    </div>
    <div class="license-icon iconfont"></div>
  </div>



              
                <div class="post-prevnext my-3">
                  <article class="post-prev col-6">
                    
                    
                      <a href="/posts/3b6899f8/" title="L9 Molecular signaling within neurons">
                        <i class="iconfont icon-arrowleft"></i>
                        <span class="hidden-mobile">L9 Molecular signaling within neurons</span>
                        <span class="visible-mobile">上一篇</span>
                      </a>
                    
                  </article>
                  <article class="post-next col-6">
                    
                    
                      <a href="/posts/168f52a5/" title="L15 Antimicrobial Drugs">
                        <span class="hidden-mobile">L15 Antimicrobial Drugs</span>
                        <span class="visible-mobile">下一篇</span>
                        <i class="iconfont icon-arrowright"></i>
                      </a>
                    
                  </article>
                </div>
              
            </div>

            
          </article>
        </div>
      </div>
    </div>

    <div class="side-col d-none d-lg-block col-lg-2">
      
  <aside class="sidebar" style="margin-left: -1rem">
    <div id="toc">
  <p class="toc-header">
    <i class="iconfont icon-list"></i>
    <span>目录</span>
  </p>
  <div class="toc-body" id="toc-body"></div>
</div>



  </aside>


    </div>
  </div>
</div>





  



  



  



  



  


  
  









    

    
      <a id="scroll-top-button" aria-label="TOP" href="#" role="button">
        <i class="iconfont icon-arrowup" aria-hidden="true"></i>
      </a>
    

    
      <div class="modal fade" id="modalSearch" tabindex="-1" role="dialog" aria-labelledby="ModalLabel"
     aria-hidden="true">
  <div class="modal-dialog modal-dialog-scrollable modal-lg" role="document">
    <div class="modal-content">
      <div class="modal-header text-center">
        <h4 class="modal-title w-100 font-weight-bold">搜索</h4>
        <button type="button" id="local-search-close" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body mx-3">
        <div class="md-form mb-5">
          <input type="text" id="local-search-input" class="form-control validate">
          <label data-error="x" data-success="v" for="local-search-input">关键词</label>
        </div>
        <div class="list-group" id="local-search-result"></div>
      </div>
    </div>
  </div>
</div>

    

    
  </main>

  <footer>
    <div class="footer-inner">
  
    <div class="footer-content">
       <a href="https://hexo.io" target="_blank" rel="nofollow noopener"><span>Hexo</span></a> <i class="iconfont icon-love"></i> <a href="https://github.com/fluid-dev/hexo-theme-fluid" target="_blank" rel="nofollow noopener"><span>Fluid</span></a> 
    </div>
  
  
  
</div>

  </footer>

  <!-- Scripts -->
  
  <script  src="https://lib.baomitu.com/nprogress/0.2.0/nprogress.min.js" ></script>
  <link  rel="stylesheet" href="https://lib.baomitu.com/nprogress/0.2.0/nprogress.min.css" />

  <script>
    NProgress.configure({"showSpinner":false,"trickleSpeed":100})
    NProgress.start()
    window.addEventListener('load', function() {
      NProgress.done();
    })
  </script>


<script  src="https://lib.baomitu.com/jquery/3.6.4/jquery.min.js" ></script>
<script  src="https://lib.baomitu.com/twitter-bootstrap/4.6.1/js/bootstrap.min.js" ></script>
<script  src="/js/events.js" ></script>
<script  src="/js/plugins.js" ></script>





  
    <script  src="/js/img-lazyload.js" ></script>
  




  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/tocbot/4.20.1/tocbot.min.js', function() {
    var toc = jQuery('#toc');
    if (toc.length === 0 || !window.tocbot) { return; }
    var boardCtn = jQuery('#board-ctn');
    var boardTop = boardCtn.offset().top;

    window.tocbot.init(Object.assign({
      tocSelector     : '#toc-body',
      contentSelector : '.markdown-body',
      linkClass       : 'tocbot-link',
      activeLinkClass : 'tocbot-active-link',
      listClass       : 'tocbot-list',
      isCollapsedClass: 'tocbot-is-collapsed',
      collapsibleClass: 'tocbot-is-collapsible',
      scrollSmooth    : true,
      includeTitleTags: true,
      headingsOffset  : -boardTop,
    }, CONFIG.toc));
    if (toc.find('.toc-list-item').length > 0) {
      toc.css('visibility', 'visible');
    }

    Fluid.events.registerRefreshCallback(function() {
      if ('tocbot' in window) {
        tocbot.refresh();
        var toc = jQuery('#toc');
        if (toc.length === 0 || !tocbot) {
          return;
        }
        if (toc.find('.toc-list-item').length > 0) {
          toc.css('visibility', 'visible');
        }
      }
    });
  });
</script>


  <script src=https://lib.baomitu.com/clipboard.js/2.0.11/clipboard.min.js></script>

  <script>Fluid.plugins.codeWidget();</script>


  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/anchor-js/5.0.0/anchor.min.js', function() {
    window.anchors.options = {
      placement: CONFIG.anchorjs.placement,
      visible  : CONFIG.anchorjs.visible
    };
    if (CONFIG.anchorjs.icon) {
      window.anchors.options.icon = CONFIG.anchorjs.icon;
    }
    var el = (CONFIG.anchorjs.element || 'h1,h2,h3,h4,h5,h6').split(',');
    var res = [];
    for (var item of el) {
      res.push('.markdown-body > ' + item.trim());
    }
    if (CONFIG.anchorjs.placement === 'left') {
      window.anchors.options.class = 'anchorjs-link-left';
    }
    window.anchors.add(res.join(', '));

    Fluid.events.registerRefreshCallback(function() {
      if ('anchors' in window) {
        anchors.removeAll();
        var el = (CONFIG.anchorjs.element || 'h1,h2,h3,h4,h5,h6').split(',');
        var res = [];
        for (var item of el) {
          res.push('.markdown-body > ' + item.trim());
        }
        if (CONFIG.anchorjs.placement === 'left') {
          anchors.options.class = 'anchorjs-link-left';
        }
        anchors.add(res.join(', '));
      }
    });
  });
</script>


  
<script>
  Fluid.utils.createScript('https://lib.baomitu.com/fancybox/3.5.7/jquery.fancybox.min.js', function() {
    Fluid.plugins.fancyBox();
  });
</script>


  <script>Fluid.plugins.imageCaption();</script>

  
      <script>
        if (!window.MathJax) {
          window.MathJax = {
            tex    : {
              inlineMath: { '[+]': [['$', '$']] }
            },
            loader : {
              load: ['ui/lazy']
            },
            options: {
              renderActions: {
                insertedScript: [200, () => {
                  document.querySelectorAll('mjx-container').forEach(node => {
                    let target = node.parentNode;
                    if (target.nodeName.toLowerCase() === 'li') {
                      target.parentNode.classList.add('has-jax');
                    }
                  });
                }, '', false]
              }
            }
          };
        } else {
          MathJax.startup.document.state(0);
          MathJax.texReset();
          MathJax.typeset();
          MathJax.typesetPromise();
        }

        Fluid.events.registerRefreshCallback(function() {
          if ('MathJax' in window && MathJax.startup.document && typeof MathJax.startup.document.state === 'function') {
            MathJax.startup.document.state(0);
            MathJax.texReset();
            MathJax.typeset();
            MathJax.typesetPromise();
          }
        });
      </script>
    

  <script  src="https://lib.baomitu.com/mathjax/3.2.2/es5/tex-mml-chtml.js" ></script>

  <script  src="/js/local-search.js" ></script>





<!-- 主题的启动项，将它保持在最底部 -->
<!-- the boot of the theme, keep it at the bottom -->
<script  src="/js/boot.js" ></script>


  

  <noscript>
    <div class="noscript-warning">博客在允许 JavaScript 运行的环境下浏览效果更佳</div>
  </noscript>
</body>
</html>
